Clinical trial of Rituximab for desensitization or antibody mediated rejection therapy in anti-donor HLA antibody positive patients

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2019
This article has no abstract
Epistemonikos ID: 655b6fd2d73a9b15a1fd114fdeec253a371594f8
First added on: Apr 11, 2025